2017-02-03

PetMed Express, Inc. (NASDAQ:PETS) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Item 5.03. Amendments to Articles of Incorporation or Bylaws;

Change in Fiscal Year.

On February 3, 2017, the Board of Directors (the Board) of PetMed

Express, Inc. (the Company), in light of current corporate

governance trends, determined it is in the best interests of the

Company and the Company’s stockholders to approve an amendment

to the Bylaws of the Company (Existing Bylaws) and has adopted

the First Amended and Restated Bylaws of the Company (First

Amended and Restated Bylaws) incorporating the amendment, to

provide for a change to the voting standard for election of

directors from a plurality voting standard to a majority voting

standard in uncontested director elections and a post-election

resignation procedure to address nominees who fail to obtain the

requisite vote. The Board believes the adoption of the majority

voting standard in uncontested director elections, and the

resignation procedures, will give the Company’s stockholders a

greater voice in determining the composition of the Board and

will enhance the accountability of each elected director to the

Company’s stockholders.

The Company’sExisting Bylaws currently provide for election of

directors by a plurality of the votes cast by the holders of

shares of capital stock entitled to vote (that is, a nominee who

receives the most FOR votes for a board seat is elected,

regardless of the number of votes WITHHELD with respect to such

nominee). The First Amended and Restated Bylaws implements a

majority voting standard, under which each director nominee in an

uncontested election must receive more FOR votes cast than

AGAINST votes cast to be elected. Conversely, a director nominee

in an uncontested election who does not receive more FOR votes

cast than AGAINST votes cast would not be elected. Votes

withheld, abstentions and broker non-votes will continue to have

no effect on the outcome of an election. In the event that an

incumbent director does not receive the requisite majority of

votes cast in an uncontested election, the Company would follow a

certain post-election resignation procedure (described below). In

all contested director elections, in which a stockholder has duly

nominated (and not withdrawn by a certain date) an individual for

election to the Board, the plurality voting standard currently in

effect would still apply.

Under the post-election resignation procedure, any incumbent

director who fails to receive the requisite number of votes for

reelection in an uncontested election will be required to

promptly tender his or her resignation to the Board. The

Corporate Governance and Nominating Committee will then make a

recommendation to the Board on whether to accept or reject the

resignation, and the Board will make the ultimate decision as to

whether to accept or reject the resignation by considering

factors it deems relevant, such as the percentage of outstanding

shares represented by the votes cast at the meeting, the director

nominee’s past and expected future contributions to the Company,

the overall composition of the Board and committees of the Board,

and whether accepting the tendered resignation would cause the

Company to fail to meet any applicable rule or regulation

(including the NASDAQ listing standards and the requirements of

the federal securities laws). The Board will act on the

resignation within 90 days following certification of the

stockholder vote for the meeting and will promptly disclose its

decision and rationale in a Current Report on Form 8-K filed with

the SEC.

The changes to the Existing Bylaws to implement the majority

voting standard and post-election resignation procedures consist

of the following:

Section 3.02(3) (Quorum and Voting Requirements for Voting

Groups) is amended to provide a cross reference to Section

3.05(1) outlining the vote required for the election of

directors;

Section 3.04(3) (Shareholder Quorum and Voting; Greater or Lesser

Voting Requirements) is amended to provide a cross reference to

Section 3.05(1) outlining the vote required for the election of

directors;

Section 3.05(1) (Voting for Directors; No Cumulative Voting) is

amended to provide for majority voting in uncontested elections,

with plurality voting retained in contested elections;

Section 4.21 (Resignation of Directors) is amended to clarify

resignations are not always effective when notice is delivered if

specified otherwise in the resignation; and

Section 4.22 (Failed Director Election) is newly added to

implement the post-election resignation procedure in the event an

incumbent director fails to receive a majority of votes cast in

an uncontested election.

The foregoing description of the First Amended and Restated

Bylaws is subject to and qualified in its entirety by reference

to the First Amended and Restated Bylaws, which is filed as

Exhibit 3.1 to this Current Report on Form 8-K and incorporated

herein by reference.

Item 9.01Financial Statements and Exhibits.

(d)

Exhibits.

3.1 First Amended and Restated Bylaws of PetMed

Express, Inc.

EXHIBIT INDEX

Exhibit No.

Description

3.1

First Amended and Restated Bylaws of PetMed Express, Inc.

About PetMed Express, Inc. (NASDAQ:PETS)
PetMed Express, Inc. (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies. Its products include brands of medication, such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution and Rimadyl. It also offers additional pet supplies for sale on its Website, which are drop shipped to its customers by third parties. These pet supplies include food, beds, crates, stairs, strollers and other pet supplies. Its products included Non-Prescription Medications (Over the Counter (OTC)) and supplies, and Prescription Medications (Rx). Its customers are located in California, Florida, Texas, New York, Virginia and Georgia, among others. PetMed Express, Inc. (NASDAQ:PETS) Recent Trading Information
PetMed Express, Inc. (NASDAQ:PETS) closed its last trading session up +0.25 at 21.32 with 253,614 shares trading hands.

The post PetMed Express, Inc. (NASDAQ:PETS) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year appeared first on Market Exclusive.

Show more